scholarly article | Q13442814 |
P2093 | author name string | Shuiping Jiang | |
Robert I. Lechler | |||
P2860 | cites work | CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice | Q78701808 |
A thymic precursor to the NK T cell lineage | Q95783850 | ||
Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity | Q24302386 | ||
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes | Q24673317 | ||
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes | Q24676786 | ||
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
B cells and professional APCs recruit regulatory T cells via CCL4 | Q28204573 | ||
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4 | Q28204758 | ||
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
Regulatory T cells overexpress a subset of Th2 gene transcripts | Q31035510 | ||
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype | Q34065191 | ||
CD25+CD4+ T cells contribute to the control of memory CD8+ T cells | Q34066063 | ||
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
Sea-level fingerprinting as a direct test for the source of global meltwater pulse IA. | Q34118671 | ||
Role of GITR in activation response of T lymphocytes. | Q34133855 | ||
Dendritic cells in transplantation--friend or foe? | Q34241103 | ||
T-cell anergy and peripheral T-cell tolerance | Q34262667 | ||
Requirement for natural killer T (NKT) cells in the induction of allograft tolerance | Q34475968 | ||
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 | ||
Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. | Q34518941 | ||
Identification of regulatory T cells in tolerated allografts | Q34524237 | ||
CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease | Q34525987 | ||
Interleukin 2 signaling is required for CD4(+) regulatory T cell function | Q34527240 | ||
Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
Inhibition of human CD4(+)CD25(+high) regulatory T cell function | Q34529239 | ||
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
NKT cells - conductors of tumor immunity? | Q34547180 | ||
Development and selection of NKT cells | Q34547258 | ||
Cell interactions in the induction of tolerance: the role of thymic lymphocytes | Q34700680 | ||
Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells | Q36346079 | ||
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action | Q36350238 | ||
Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice | Q36353590 | ||
Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. | Q36362779 | ||
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
Peripheral autoantigen induces regulatory T cells that prevent autoimmunity | Q36367859 | ||
Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease | Q36368026 | ||
CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade | Q36369151 | ||
Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells | Q36369536 | ||
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. | Q36369797 | ||
A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage | Q36370202 | ||
Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells | Q36370232 | ||
In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines | Q36370322 | ||
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis | Q36376571 | ||
Testing the NKT cell hypothesis of human IDDM pathogenesis | Q39738424 | ||
NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance | Q40723327 | ||
Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 | ||
IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. | Q40811244 | ||
Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice | Q40881650 | ||
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
Anergic T cells as suppressor cells in vitro | Q41461549 | ||
Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 | ||
Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood | Q41973912 | ||
Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood | Q41988688 | ||
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis | Q42943192 | ||
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. | Q42944882 | ||
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells | Q42947524 | ||
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells | Q43756252 | ||
Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans | Q45221904 | ||
Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. | Q45972944 | ||
A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood | Q46284741 | ||
Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency | Q47992795 | ||
Tracking the immunoregulatory mechanisms active during allograft tolerance | Q49022949 | ||
Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. | Q52899971 | ||
Immune suppression and skin cancer development: regulation by NKT cells. | Q53400482 | ||
Infectious immunological tolerance | Q54033162 | ||
Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance | Q56904417 | ||
CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 | ||
CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells | Q58826830 | ||
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 | ||
Dominant transplantation tolerance impairs CD8+ T cell function but not expansion | Q61651663 | ||
The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice | Q63363340 | ||
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway | Q73256881 | ||
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression | Q73977252 | ||
Anergic T cells inhibit the antigen-presenting function of dendritic cells | Q74027073 | ||
Anergic T cells effect linked suppression | Q74179247 | ||
Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells | Q74244102 | ||
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen | Q74286698 | ||
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes | Q74455329 | ||
Anergic T cells act as suppressor cells in vitro and in vivo | Q74578866 | ||
The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 | Q74650540 | ||
CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 | Q74660381 | ||
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells | Q77291206 | ||
Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells | Q77584492 | ||
Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
Intratracheal delivery of a single major histocompatibility complex class I peptide induced prolonged survival of fully allogeneic cardiac grafts and generated regulatory cells | Q78339262 | ||
Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy | Q78488897 | ||
NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells | Q78651183 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 516-524 | |
P577 | publication date | 2003-05-01 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Regulatory T cells in the control of transplantation tolerance and autoimmunity | |
Regulatory T Cells in the Control of Transplantation Tolerance and Autoimmunity | |||
P478 | volume | 3 |
Q80696372 | A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury |
Q79438875 | Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance |
Q38398029 | Analysis of FOXP3 gene and protein expressions in renal allograft biopsies and their association with graft outcomes. |
Q46907594 | Apoptosis of allospecifically activated human helper T cells is blocked by calcineurin inhibition. |
Q38081174 | CD4(+) T-cell subsets in transplantation |
Q53895280 | CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. |
Q36600237 | CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance |
Q37754524 | CD4+CD25+ regulatory T-cell therapy |
Q40106370 | CD4+CD25+Foxp3+ indirect alloreactive T cells from renal transplant patients suppress both the direct and indirect pathways of allorecognition. |
Q38671746 | Can immunosuppression be stopped after liver transplantation? |
Q95379921 | Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation |
Q47864673 | Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy |
Q53257699 | Curcumin, myrecen and cineol modulate the percentage of lymphocyte subsets altered by 2,3,7, 8-tetracholorodibenzo-p-dioxins (TCDD) in rats. |
Q51364475 | Dendritic cells and regulation of alloimmune responses: relevance to outcome and therapy of organ transplantation. |
Q36868786 | Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells |
Q46844016 | Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin |
Q37191195 | Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity. |
Q37937127 | FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance |
Q35549155 | Individuality: the barrier to optimal immunosuppression |
Q45141050 | Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123. |
Q33883569 | Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression |
Q53591791 | Presence of functional mouse regulatory CD4+CD25+T cells in xenogeneic neonatal porcine thymus-grafted athymic mice. |
Q37721479 | Recent progress and new perspectives in studying T cell responses to allografts |
Q33945960 | Reconstitution of self-tolerance after hematopoietic stem cell transplantation |
Q35044185 | Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts |
Q36738543 | Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance |
Q38223097 | Role of autoimmune responses in periodontal disease |
Q57702531 | Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion |
Q45342464 | The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection |
Q34071745 | The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity |
Q35893645 | The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials |
Q28079523 | Tolerance in liver transplantation: Biomarkers and clinical relevance |